Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neuin a murine mammary carcinoma model
2004 · Breast Cancer Research · 93 citations
https://doi.org/10.1186/bcr787
L
Lawrence B. Lachman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
80
Papers
6.0K
Citations
33
h-index
49
i10-index
Lawrence B. Lachman is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Immune Response and Inflammation & Immunotherapy and Immune Responses & Immune Cell Function and Interaction. The author has an h-index of 33, co-authored 68 publications.
Papers by this author
worksDNA vaccination against neu reduces breast cancer incidence and metastasis in mice
2001 · Cancer Gene Therapy · 73 citations
https://doi.org/10.1038/sj.cgt.7700300
Prime–boost vaccination with plasmid and adenovirus gene vaccines control HER2/neu +metastatic breast cancer in mice
2005 · Breast Cancer Research · 53 citations
https://doi.org/10.1186/bcr1199
Secretion of IL-1: role of protein kinase C
1992 · The Journal of Immunology · 47 citations
https://doi.org/10.4049/jimmunol.148.1.84
Alphavirus replicon particles containing the gene for HER2/neuinhibit breast cancer growth and tumorigenesis
2004 · Breast Cancer Research · 43 citations
https://doi.org/10.1186/bcr962
Acylation of cell-associated IL-1 by palmitic acid
1991 · The Journal of Immunology · 8 citations
https://doi.org/10.4049/jimmunol.147.7.2164
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat